nodes	percent_of_prediction	percent_of_DWPC	metapath
Trazodone—SLC6A4—chronic obstructive pulmonary disease	0.311	0.565	CbGaD
Trazodone—HTR2A—chronic obstructive pulmonary disease	0.239	0.435	CbGaD
Trazodone—CYP2D6—Formoterol—chronic obstructive pulmonary disease	0.0335	0.147	CbGbCtD
Trazodone—CYP2D6—Arformoterol—chronic obstructive pulmonary disease	0.0335	0.147	CbGbCtD
Trazodone—CYP2D6—Tiotropium—chronic obstructive pulmonary disease	0.0299	0.131	CbGbCtD
Trazodone—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.0281	0.124	CbGbCtD
Trazodone—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.019	0.0835	CbGbCtD
Trazodone—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.0181	0.0797	CbGbCtD
Trazodone—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.0161	0.071	CbGbCtD
Trazodone—ABCB1—Prednisolone—chronic obstructive pulmonary disease	0.0158	0.0695	CbGbCtD
Trazodone—ABCB1—Prednisone—chronic obstructive pulmonary disease	0.0149	0.0657	CbGbCtD
Trazodone—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.00947	0.0417	CbGbCtD
Trazodone—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.00894	0.0393	CbGbCtD
Trazodone—HTR2A—phrenic nerve—chronic obstructive pulmonary disease	0.00703	0.368	CbGeAlD
Trazodone—HTR2A—pulmonary artery—chronic obstructive pulmonary disease	0.00255	0.134	CbGeAlD
Trazodone—Vilazodone—SLC6A4—chronic obstructive pulmonary disease	0.000885	0.167	CrCbGaD
Trazodone—SLC6A4—respiratory system—chronic obstructive pulmonary disease	0.000811	0.0425	CbGeAlD
Trazodone—HTR2B—smooth muscle tissue—chronic obstructive pulmonary disease	0.000647	0.0339	CbGeAlD
Trazodone—CYP3A5—respiratory system—chronic obstructive pulmonary disease	0.000529	0.0278	CbGeAlD
Trazodone—HRH1—respiratory system—chronic obstructive pulmonary disease	0.000514	0.0269	CbGeAlD
Trazodone—ORM1—lung—chronic obstructive pulmonary disease	0.000505	0.0265	CbGeAlD
Trazodone—HRH1—connective tissue—chronic obstructive pulmonary disease	0.000452	0.0237	CbGeAlD
Trazodone—ADRA2A—connective tissue—chronic obstructive pulmonary disease	0.000444	0.0233	CbGeAlD
Trazodone—SLC6A4—lung—chronic obstructive pulmonary disease	0.000431	0.0226	CbGeAlD
Trazodone—HTR2A—respiratory system—chronic obstructive pulmonary disease	0.000429	0.0225	CbGeAlD
Trazodone—HTR2B—lung—chronic obstructive pulmonary disease	0.000427	0.0224	CbGeAlD
Trazodone—ADRA2A—bronchus—chronic obstructive pulmonary disease	0.000415	0.0218	CbGeAlD
Trazodone—HRH1—smooth muscle tissue—chronic obstructive pulmonary disease	0.000414	0.0217	CbGeAlD
Trazodone—HRH1—trachea—chronic obstructive pulmonary disease	0.00038	0.0199	CbGeAlD
Trazodone—HTR2A—connective tissue—chronic obstructive pulmonary disease	0.000378	0.0198	CbGeAlD
Trazodone—ADRA2A—trachea—chronic obstructive pulmonary disease	0.000373	0.0196	CbGeAlD
Trazodone—HTR2A—smooth muscle tissue—chronic obstructive pulmonary disease	0.000346	0.0181	CbGeAlD
Trazodone—Ziprasidone—SLC6A4—chronic obstructive pulmonary disease	0.000335	0.0632	CrCbGaD
Trazodone—HTR2A—trachea—chronic obstructive pulmonary disease	0.000317	0.0166	CbGeAlD
Trazodone—Domperidone—CYP1A2—chronic obstructive pulmonary disease	0.000309	0.0583	CrCbGaD
Trazodone—Ziprasidone—CYP1A2—chronic obstructive pulmonary disease	0.000305	0.0576	CrCbGaD
Trazodone—Nefazodone—SLC6A4—chronic obstructive pulmonary disease	0.000282	0.0531	CrCbGaD
Trazodone—ABCB1—respiratory system—chronic obstructive pulmonary disease	0.000281	0.0147	CbGeAlD
Trazodone—CYP3A5—lung—chronic obstructive pulmonary disease	0.000281	0.0147	CbGeAlD
Trazodone—Paraesthesia—Tiotropium—chronic obstructive pulmonary disease	0.000278	0.00184	CcSEcCtD
Trazodone—Malaise—Arformoterol—chronic obstructive pulmonary disease	0.000276	0.00182	CcSEcCtD
Trazodone—Malaise—Formoterol—chronic obstructive pulmonary disease	0.000276	0.00182	CcSEcCtD
Trazodone—Agitation—Montelukast—chronic obstructive pulmonary disease	0.000276	0.00182	CcSEcCtD
Trazodone—HRH1—lung—chronic obstructive pulmonary disease	0.000273	0.0143	CbGeAlD
Trazodone—Tremor—Salbutamol—chronic obstructive pulmonary disease	0.000271	0.00179	CcSEcCtD
Trazodone—Palpitations—Arformoterol—chronic obstructive pulmonary disease	0.000271	0.00179	CcSEcCtD
Trazodone—Palpitations—Formoterol—chronic obstructive pulmonary disease	0.000271	0.00179	CcSEcCtD
Trazodone—Gastrointestinal pain—Aminophylline—chronic obstructive pulmonary disease	0.000269	0.00177	CcSEcCtD
Trazodone—Ill-defined disorder—Salbutamol—chronic obstructive pulmonary disease	0.000268	0.00177	CcSEcCtD
Trazodone—ADRA2A—lung—chronic obstructive pulmonary disease	0.000268	0.014	CbGeAlD
Trazodone—Agitation—Salbutamol—chronic obstructive pulmonary disease	0.000266	0.00176	CcSEcCtD
Trazodone—Palpitations—Montelukast—chronic obstructive pulmonary disease	0.000265	0.00175	CcSEcCtD
Trazodone—Constipation—Tiotropium—chronic obstructive pulmonary disease	0.000265	0.00175	CcSEcCtD
Trazodone—Hypertension—Arformoterol—chronic obstructive pulmonary disease	0.000264	0.00175	CcSEcCtD
Trazodone—Hypertension—Formoterol—chronic obstructive pulmonary disease	0.000264	0.00175	CcSEcCtD
Trazodone—Cardiac arrest—Prednisolone—chronic obstructive pulmonary disease	0.000262	0.00173	CcSEcCtD
Trazodone—Aripiprazole—SLC6A4—chronic obstructive pulmonary disease	0.000262	0.0494	CrCbGaD
Trazodone—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.000261	0.00172	CcSEcCtD
Trazodone—Malaise—Salbutamol—chronic obstructive pulmonary disease	0.000261	0.00172	CcSEcCtD
Trazodone—Arthralgia—Formoterol—chronic obstructive pulmonary disease	0.000261	0.00172	CcSEcCtD
Trazodone—Chest pain—Arformoterol—chronic obstructive pulmonary disease	0.000261	0.00172	CcSEcCtD
Trazodone—Arthralgia—Arformoterol—chronic obstructive pulmonary disease	0.000261	0.00172	CcSEcCtD
Trazodone—Myalgia—Arformoterol—chronic obstructive pulmonary disease	0.000261	0.00172	CcSEcCtD
Trazodone—Myalgia—Formoterol—chronic obstructive pulmonary disease	0.000261	0.00172	CcSEcCtD
Trazodone—Chest pain—Formoterol—chronic obstructive pulmonary disease	0.000261	0.00172	CcSEcCtD
Trazodone—Anxiety—Arformoterol—chronic obstructive pulmonary disease	0.00026	0.00172	CcSEcCtD
Trazodone—Anxiety—Formoterol—chronic obstructive pulmonary disease	0.00026	0.00172	CcSEcCtD
Trazodone—Vertigo—Salbutamol—chronic obstructive pulmonary disease	0.00026	0.00172	CcSEcCtD
Trazodone—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.00026	0.00172	CcSEcCtD
Trazodone—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.00026	0.00172	CcSEcCtD
Trazodone—Syncope—Salbutamol—chronic obstructive pulmonary disease	0.000259	0.00171	CcSEcCtD
Trazodone—Discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000258	0.0017	CcSEcCtD
Trazodone—Discomfort—Formoterol—chronic obstructive pulmonary disease	0.000258	0.0017	CcSEcCtD
Trazodone—Ziprasidone—HTR2A—chronic obstructive pulmonary disease	0.000257	0.0486	CrCbGaD
Trazodone—Palpitations—Salbutamol—chronic obstructive pulmonary disease	0.000256	0.00169	CcSEcCtD
Trazodone—Arthralgia—Montelukast—chronic obstructive pulmonary disease	0.000255	0.00169	CcSEcCtD
Trazodone—Myalgia—Montelukast—chronic obstructive pulmonary disease	0.000255	0.00169	CcSEcCtD
Trazodone—Dry mouth—Formoterol—chronic obstructive pulmonary disease	0.000255	0.00168	CcSEcCtD
Trazodone—Dry mouth—Arformoterol—chronic obstructive pulmonary disease	0.000255	0.00168	CcSEcCtD
Trazodone—Anxiety—Montelukast—chronic obstructive pulmonary disease	0.000254	0.00168	CcSEcCtD
Trazodone—Loss of consciousness—Salbutamol—chronic obstructive pulmonary disease	0.000254	0.00168	CcSEcCtD
Trazodone—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.000253	0.00167	CcSEcCtD
Trazodone—Oedema—Arformoterol—chronic obstructive pulmonary disease	0.00025	0.00165	CcSEcCtD
Trazodone—Oedema—Formoterol—chronic obstructive pulmonary disease	0.00025	0.00165	CcSEcCtD
Trazodone—Hypertension—Salbutamol—chronic obstructive pulmonary disease	0.00025	0.00165	CcSEcCtD
Trazodone—Chest pain—Salbutamol—chronic obstructive pulmonary disease	0.000246	0.00163	CcSEcCtD
Trazodone—Myalgia—Salbutamol—chronic obstructive pulmonary disease	0.000246	0.00163	CcSEcCtD
Trazodone—Arthralgia—Salbutamol—chronic obstructive pulmonary disease	0.000246	0.00163	CcSEcCtD
Trazodone—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.000246	0.00163	CcSEcCtD
Trazodone—Anxiety—Salbutamol—chronic obstructive pulmonary disease	0.000245	0.00162	CcSEcCtD
Trazodone—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.000245	0.00162	CcSEcCtD
Trazodone—Oedema—Montelukast—chronic obstructive pulmonary disease	0.000245	0.00162	CcSEcCtD
Trazodone—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.000244	0.00161	CcSEcCtD
Trazodone—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.000244	0.00161	CcSEcCtD
Trazodone—Discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000243	0.00161	CcSEcCtD
Trazodone—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.000242	0.0016	CcSEcCtD
Trazodone—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.000241	0.00159	CcSEcCtD
Trazodone—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.000236	0.00156	CcSEcCtD
Trazodone—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.000234	0.00154	CcSEcCtD
Trazodone—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.000234	0.00154	CcSEcCtD
Trazodone—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000232	0.00154	CcSEcCtD
Trazodone—Shock—Salbutamol—chronic obstructive pulmonary disease	0.000232	0.00153	CcSEcCtD
Trazodone—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.00023	0.00152	CcSEcCtD
Trazodone—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000228	0.00151	CcSEcCtD
Trazodone—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.000228	0.00151	CcSEcCtD
Trazodone—HTR2A—lung—chronic obstructive pulmonary disease	0.000228	0.0119	CbGeAlD
Trazodone—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.000228	0.0015	CcSEcCtD
Trazodone—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000228	0.0015	CcSEcCtD
Trazodone—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.000226	0.00149	CcSEcCtD
Trazodone—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.000226	0.00149	CcSEcCtD
Trazodone—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.000225	0.00149	CcSEcCtD
Trazodone—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000225	0.00148	CcSEcCtD
Trazodone—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.000223	0.00147	CcSEcCtD
Trazodone—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.000223	0.00147	CcSEcCtD
Trazodone—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.000223	0.00147	CcSEcCtD
Trazodone—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000222	0.00147	CcSEcCtD
Trazodone—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000222	0.00147	CcSEcCtD
Trazodone—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.000221	0.00146	CcSEcCtD
Trazodone—Cardiac failure congestive—Prednisone—chronic obstructive pulmonary disease	0.000221	0.00146	CcSEcCtD
Trazodone—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.000221	0.00146	CcSEcCtD
Trazodone—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.00022	0.00145	CcSEcCtD
Trazodone—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000219	0.00145	CcSEcCtD
Trazodone—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000218	0.00144	CcSEcCtD
Trazodone—Zuclopenthixol—HTR2A—chronic obstructive pulmonary disease	0.000218	0.0411	CrCbGaD
Trazodone—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000217	0.00143	CcSEcCtD
Trazodone—Weight increased—Prednisolone—chronic obstructive pulmonary disease	0.000217	0.00143	CcSEcCtD
Trazodone—Nefazodone—HTR2A—chronic obstructive pulmonary disease	0.000216	0.0408	CrCbGaD
Trazodone—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.000215	0.00142	CcSEcCtD
Trazodone—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.000215	0.00142	CcSEcCtD
Trazodone—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000215	0.00142	CcSEcCtD
Trazodone—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.000214	0.00141	CcSEcCtD
Trazodone—Pain—Formoterol—chronic obstructive pulmonary disease	0.000214	0.00141	CcSEcCtD
Trazodone—Constipation—Formoterol—chronic obstructive pulmonary disease	0.000214	0.00141	CcSEcCtD
Trazodone—Pain—Arformoterol—chronic obstructive pulmonary disease	0.000214	0.00141	CcSEcCtD
Trazodone—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.000213	0.00141	CcSEcCtD
Trazodone—Increased appetite—Prednisone—chronic obstructive pulmonary disease	0.000213	0.00141	CcSEcCtD
Trazodone—Amnesia—Prednisone—chronic obstructive pulmonary disease	0.000213	0.00141	CcSEcCtD
Trazodone—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.000212	0.0014	CcSEcCtD
Trazodone—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.000211	0.00139	CcSEcCtD
Trazodone—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.00021	0.00139	CcSEcCtD
Trazodone—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.00021	0.00139	CcSEcCtD
Trazodone—Pain—Montelukast—chronic obstructive pulmonary disease	0.000209	0.00138	CcSEcCtD
Trazodone—Acute coronary syndrome—Prednisolone—chronic obstructive pulmonary disease	0.000209	0.00138	CcSEcCtD
Trazodone—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000209	0.00138	CcSEcCtD
Trazodone—Myocardial infarction—Prednisolone—chronic obstructive pulmonary disease	0.000208	0.00137	CcSEcCtD
Trazodone—ABCB1—trachea—chronic obstructive pulmonary disease	0.000208	0.0109	CbGeAlD
Trazodone—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000207	0.00137	CcSEcCtD
Trazodone—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000207	0.00137	CcSEcCtD
Trazodone—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000206	0.00136	CcSEcCtD
Trazodone—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000206	0.00136	CcSEcCtD
Trazodone—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000206	0.00136	CcSEcCtD
Trazodone—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.000205	0.00136	CcSEcCtD
Trazodone—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000205	0.00135	CcSEcCtD
Trazodone—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000204	0.00135	CcSEcCtD
Trazodone—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000204	0.00135	CcSEcCtD
Trazodone—Lethargy—Prednisone—chronic obstructive pulmonary disease	0.000204	0.00135	CcSEcCtD
Trazodone—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.000203	0.00134	CcSEcCtD
Trazodone—Pain—Salbutamol—chronic obstructive pulmonary disease	0.000202	0.00133	CcSEcCtD
Trazodone—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.000202	0.00133	CcSEcCtD
Trazodone—Aripiprazole—HTR2A—chronic obstructive pulmonary disease	0.000201	0.038	CrCbGaD
Trazodone—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.0002	0.00132	CcSEcCtD
Trazodone—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000199	0.00131	CcSEcCtD
Trazodone—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000199	0.00131	CcSEcCtD
Trazodone—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000198	0.00131	CcSEcCtD
Trazodone—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.000198	0.00131	CcSEcCtD
Trazodone—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000198	0.00131	CcSEcCtD
Trazodone—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.000198	0.00131	CcSEcCtD
Trazodone—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000197	0.0013	CcSEcCtD
Trazodone—Psychotic disorder—Prednisone—chronic obstructive pulmonary disease	0.000195	0.00129	CcSEcCtD
Trazodone—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000195	0.00129	CcSEcCtD
Trazodone—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000195	0.00129	CcSEcCtD
Trazodone—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000195	0.00129	CcSEcCtD
Trazodone—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000194	0.00128	CcSEcCtD
Trazodone—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000194	0.00128	CcSEcCtD
Trazodone—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000194	0.00128	CcSEcCtD
Trazodone—Bradycardia—Prednisolone—chronic obstructive pulmonary disease	0.000194	0.00128	CcSEcCtD
Trazodone—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.000194	0.00128	CcSEcCtD
Trazodone—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000194	0.00128	CcSEcCtD
Trazodone—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000193	0.00128	CcSEcCtD
Trazodone—Fluphenazine—CYP1A2—chronic obstructive pulmonary disease	0.000192	0.0363	CrCbGaD
Trazodone—Thioproperazine—HTR2A—chronic obstructive pulmonary disease	0.000191	0.036	CrCbGaD
Trazodone—Cardiac arrest—Prednisone—chronic obstructive pulmonary disease	0.00019	0.00126	CcSEcCtD
Trazodone—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000187	0.00124	CcSEcCtD
Trazodone—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000187	0.00123	CcSEcCtD
Trazodone—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000187	0.00123	CcSEcCtD
Trazodone—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000184	0.00122	CcSEcCtD
Trazodone—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000184	0.00122	CcSEcCtD
Trazodone—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000184	0.00122	CcSEcCtD
Trazodone—Visual impairment—Prednisolone—chronic obstructive pulmonary disease	0.000184	0.00121	CcSEcCtD
Trazodone—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.00018	0.00119	CcSEcCtD
Trazodone—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000179	0.00118	CcSEcCtD
Trazodone—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000179	0.00118	CcSEcCtD
Trazodone—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000177	0.00117	CcSEcCtD
Trazodone—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000177	0.00117	CcSEcCtD
Trazodone—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000176	0.00116	CcSEcCtD
Trazodone—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000174	0.00115	CcSEcCtD
Trazodone—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000173	0.00114	CcSEcCtD
Trazodone—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000171	0.00113	CcSEcCtD
Trazodone—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000171	0.00113	CcSEcCtD
Trazodone—Arrhythmia—Prednisolone—chronic obstructive pulmonary disease	0.00017	0.00112	CcSEcCtD
Trazodone—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000169	0.00112	CcSEcCtD
Trazodone—Loxapine—SLC6A4—chronic obstructive pulmonary disease	0.000168	0.0316	CrCbGaD
Trazodone—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000167	0.00111	CcSEcCtD
Trazodone—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000167	0.0011	CcSEcCtD
Trazodone—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000165	0.00109	CcSEcCtD
Trazodone—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000165	0.00109	CcSEcCtD
Trazodone—Fluphenazine—HTR2A—chronic obstructive pulmonary disease	0.000162	0.0306	CrCbGaD
Trazodone—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000162	0.00107	CcSEcCtD
Trazodone—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000161	0.00107	CcSEcCtD
Trazodone—Erectile dysfunction—Prednisone—chronic obstructive pulmonary disease	0.000159	0.00105	CcSEcCtD
Trazodone—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000159	0.00105	CcSEcCtD
Trazodone—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000159	0.00105	CcSEcCtD
Trazodone—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000158	0.00104	CcSEcCtD
Trazodone—Rash—Formoterol—chronic obstructive pulmonary disease	0.000158	0.00104	CcSEcCtD
Trazodone—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000157	0.00104	CcSEcCtD
Trazodone—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000157	0.00104	CcSEcCtD
Trazodone—Weight increased—Prednisone—chronic obstructive pulmonary disease	0.000157	0.00104	CcSEcCtD
Trazodone—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000157	0.00103	CcSEcCtD
Trazodone—Headache—Formoterol—chronic obstructive pulmonary disease	0.000157	0.00103	CcSEcCtD
Trazodone—Weight decreased—Prednisone—chronic obstructive pulmonary disease	0.000156	0.00103	CcSEcCtD
Trazodone—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	0.000156	0.00103	CcSEcCtD
Trazodone—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000156	0.00103	CcSEcCtD
Trazodone—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000156	0.00103	CcSEcCtD
Trazodone—Rash—Montelukast—chronic obstructive pulmonary disease	0.000154	0.00102	CcSEcCtD
Trazodone—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000154	0.00102	CcSEcCtD
Trazodone—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	0.000154	0.00102	CcSEcCtD
Trazodone—Trifluoperazine—CYP1A2—chronic obstructive pulmonary disease	0.000154	0.029	CrCbGaD
Trazodone—Headache—Montelukast—chronic obstructive pulmonary disease	0.000153	0.00101	CcSEcCtD
Trazodone—Acute coronary syndrome—Prednisone—chronic obstructive pulmonary disease	0.000152	0.001	CcSEcCtD
Trazodone—Perphenazine—CYP1A2—chronic obstructive pulmonary disease	0.000152	0.0287	CrCbGaD
Trazodone—Myocardial infarction—Prednisone—chronic obstructive pulmonary disease	0.000151	0.000999	CcSEcCtD
Trazodone—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.00015	0.000991	CcSEcCtD
Trazodone—Malaise—Prednisolone—chronic obstructive pulmonary disease	0.00015	0.000988	CcSEcCtD
Trazodone—ABCB1—lung—chronic obstructive pulmonary disease	0.000149	0.00783	CbGeAlD
Trazodone—Vertigo—Prednisolone—chronic obstructive pulmonary disease	0.000149	0.000985	CcSEcCtD
Trazodone—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000149	0.000983	CcSEcCtD
Trazodone—Syncope—Prednisolone—chronic obstructive pulmonary disease	0.000149	0.000983	CcSEcCtD
Trazodone—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000149	0.000982	CcSEcCtD
Trazodone—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000148	0.000981	CcSEcCtD
Trazodone—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000148	0.000981	CcSEcCtD
Trazodone—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000148	0.000977	CcSEcCtD
Trazodone—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	0.000146	0.000963	CcSEcCtD
Trazodone—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000145	0.000961	CcSEcCtD
Trazodone—Hypertension—Prednisolone—chronic obstructive pulmonary disease	0.000143	0.000946	CcSEcCtD
Trazodone—Bradycardia—Prednisone—chronic obstructive pulmonary disease	0.000141	0.000931	CcSEcCtD
Trazodone—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.00014	0.000926	CcSEcCtD
Trazodone—Discomfort—Prednisolone—chronic obstructive pulmonary disease	0.00014	0.000922	CcSEcCtD
Trazodone—Hallucination—Prednisone—chronic obstructive pulmonary disease	0.000138	0.00091	CcSEcCtD
Trazodone—Oedema—Prednisolone—chronic obstructive pulmonary disease	0.000135	0.000894	CcSEcCtD
Trazodone—Shock—Prednisolone—chronic obstructive pulmonary disease	0.000133	0.00088	CcSEcCtD
Trazodone—Clozapine—CYP1A1—chronic obstructive pulmonary disease	0.000133	0.0251	CrCbGaD
Trazodone—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	0.000132	0.000873	CcSEcCtD
Trazodone—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	0.000131	0.000865	CcSEcCtD
Trazodone—Thioproperazine—ALB—chronic obstructive pulmonary disease	0.00013	0.0246	CrCbGaD
Trazodone—Trifluoperazine—HTR2A—chronic obstructive pulmonary disease	0.00013	0.0245	CrCbGaD
Trazodone—Loxapine—HTR2A—chronic obstructive pulmonary disease	0.000129	0.0243	CrCbGaD
Trazodone—Flushing—Prednisone—chronic obstructive pulmonary disease	0.000128	0.000849	CcSEcCtD
Trazodone—Perphenazine—HTR2A—chronic obstructive pulmonary disease	0.000128	0.0242	CrCbGaD
Trazodone—Clozapine—CYP1A2—chronic obstructive pulmonary disease	0.000128	0.0242	CrCbGaD
Trazodone—Quetiapine—HTR2A—chronic obstructive pulmonary disease	0.000126	0.0237	CrCbGaD
Trazodone—Arrhythmia—Prednisone—chronic obstructive pulmonary disease	0.000124	0.000817	CcSEcCtD
Trazodone—Insomnia—Prednisolone—chronic obstructive pulmonary disease	0.000122	0.000809	CcSEcCtD
Trazodone—Alopecia—Prednisone—chronic obstructive pulmonary disease	0.000122	0.000808	CcSEcCtD
Trazodone—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	0.000122	0.000803	CcSEcCtD
Trazodone—Pain—Prednisolone—chronic obstructive pulmonary disease	0.000116	0.000765	CcSEcCtD
Trazodone—Vision blurred—Prednisone—chronic obstructive pulmonary disease	0.000114	0.00075	CcSEcCtD
Trazodone—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	0.000112	0.000739	CcSEcCtD
Trazodone—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.000112	0.000737	CcSEcCtD
Trazodone—Anaemia—Prednisone—chronic obstructive pulmonary disease	0.000111	0.000736	CcSEcCtD
Trazodone—Agitation—Prednisone—chronic obstructive pulmonary disease	0.000111	0.000732	CcSEcCtD
Trazodone—Malaise—Prednisone—chronic obstructive pulmonary disease	0.000109	0.000718	CcSEcCtD
Trazodone—Vertigo—Prednisone—chronic obstructive pulmonary disease	0.000108	0.000715	CcSEcCtD
Trazodone—Clozapine—HTR2A—chronic obstructive pulmonary disease	0.000108	0.0204	CrCbGaD
Trazodone—Syncope—Prednisone—chronic obstructive pulmonary disease	0.000108	0.000714	CcSEcCtD
Trazodone—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.000108	0.00071	CcSEcCtD
Trazodone—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	0.000106	0.0007	CcSEcCtD
Trazodone—Hypertension—Prednisone—chronic obstructive pulmonary disease	0.000104	0.000687	CcSEcCtD
Trazodone—Arthralgia—Prednisone—chronic obstructive pulmonary disease	0.000103	0.000678	CcSEcCtD
Trazodone—Myalgia—Prednisone—chronic obstructive pulmonary disease	0.000103	0.000678	CcSEcCtD
Trazodone—Anxiety—Prednisone—chronic obstructive pulmonary disease	0.000102	0.000676	CcSEcCtD
Trazodone—Discomfort—Prednisone—chronic obstructive pulmonary disease	0.000101	0.00067	CcSEcCtD
Trazodone—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	9.97e-05	0.000659	CcSEcCtD
Trazodone—Oedema—Prednisone—chronic obstructive pulmonary disease	9.84e-05	0.00065	CcSEcCtD
Trazodone—Shock—Prednisone—chronic obstructive pulmonary disease	9.68e-05	0.000639	CcSEcCtD
Trazodone—Tachycardia—Prednisone—chronic obstructive pulmonary disease	9.6e-05	0.000634	CcSEcCtD
Trazodone—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	9.51e-05	0.000628	CcSEcCtD
Trazodone—Anorexia—Prednisone—chronic obstructive pulmonary disease	9.38e-05	0.000619	CcSEcCtD
Trazodone—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	8.96e-05	0.000592	CcSEcCtD
Trazodone—Dizziness—Prednisolone—chronic obstructive pulmonary disease	8.95e-05	0.000591	CcSEcCtD
Trazodone—Insomnia—Prednisone—chronic obstructive pulmonary disease	8.9e-05	0.000588	CcSEcCtD
Trazodone—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	8.83e-05	0.000584	CcSEcCtD
Trazodone—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	8.55e-05	0.000565	CcSEcCtD
Trazodone—Rash—Prednisolone—chronic obstructive pulmonary disease	8.53e-05	0.000564	CcSEcCtD
Trazodone—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	8.53e-05	0.000563	CcSEcCtD
Trazodone—Fatigue—Prednisone—chronic obstructive pulmonary disease	8.48e-05	0.00056	CcSEcCtD
Trazodone—Headache—Prednisolone—chronic obstructive pulmonary disease	8.48e-05	0.00056	CcSEcCtD
Trazodone—Constipation—Prednisone—chronic obstructive pulmonary disease	8.41e-05	0.000556	CcSEcCtD
Trazodone—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	8.11e-05	0.000536	CcSEcCtD
Trazodone—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	8.04e-05	0.000531	CcSEcCtD
Trazodone—Nausea—Prednisolone—chronic obstructive pulmonary disease	8.04e-05	0.000531	CcSEcCtD
Trazodone—Urticaria—Prednisone—chronic obstructive pulmonary disease	7.81e-05	0.000516	CcSEcCtD
Trazodone—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	7.78e-05	0.000514	CcSEcCtD
Trazodone—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	7.78e-05	0.000514	CcSEcCtD
Trazodone—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	7.25e-05	0.000479	CcSEcCtD
Trazodone—Asthenia—Prednisone—chronic obstructive pulmonary disease	7.06e-05	0.000466	CcSEcCtD
Trazodone—Pruritus—Prednisone—chronic obstructive pulmonary disease	6.96e-05	0.00046	CcSEcCtD
Trazodone—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	6.73e-05	0.000445	CcSEcCtD
Trazodone—Dizziness—Prednisone—chronic obstructive pulmonary disease	6.5e-05	0.00043	CcSEcCtD
Trazodone—Vomiting—Prednisone—chronic obstructive pulmonary disease	6.25e-05	0.000413	CcSEcCtD
Trazodone—Rash—Prednisone—chronic obstructive pulmonary disease	6.2e-05	0.00041	CcSEcCtD
Trazodone—Dermatitis—Prednisone—chronic obstructive pulmonary disease	6.2e-05	0.000409	CcSEcCtD
Trazodone—Headache—Prednisone—chronic obstructive pulmonary disease	6.16e-05	0.000407	CcSEcCtD
Trazodone—Nausea—Prednisone—chronic obstructive pulmonary disease	5.84e-05	0.000386	CcSEcCtD
Trazodone—HTR1A—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	1.83e-05	0.000395	CbGpPWpGaD
Trazodone—HTR2C—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	1.82e-05	0.000393	CbGpPWpGaD
Trazodone—CYP3A7—Metabolism—CTGF—chronic obstructive pulmonary disease	1.81e-05	0.000389	CbGpPWpGaD
Trazodone—ADRA2A—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	1.78e-05	0.000383	CbGpPWpGaD
Trazodone—HTR2A—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	1.77e-05	0.000382	CbGpPWpGaD
Trazodone—HRH1—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	1.77e-05	0.000381	CbGpPWpGaD
Trazodone—HTR1A—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	1.77e-05	0.000381	CbGpPWpGaD
Trazodone—HTR2C—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	1.76e-05	0.000379	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.75e-05	0.000377	CbGpPWpGaD
Trazodone—HTR2A—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	1.74e-05	0.000376	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	1.74e-05	0.000375	CbGpPWpGaD
Trazodone—HRH1—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	1.74e-05	0.000375	CbGpPWpGaD
Trazodone—ADRA1A—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	1.74e-05	0.000374	CbGpPWpGaD
Trazodone—ADRA1A—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	1.71e-05	0.000368	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	1.67e-05	0.00036	CbGpPWpGaD
Trazodone—HTR2A—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	1.67e-05	0.000359	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	1.67e-05	0.000359	CbGpPWpGaD
Trazodone—HRH1—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	1.67e-05	0.000359	CbGpPWpGaD
Trazodone—CYP3A7—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.66e-05	0.000359	CbGpPWpGaD
Trazodone—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—chronic obstructive pulmonary disease	1.66e-05	0.000358	CbGpPWpGaD
Trazodone—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	1.66e-05	0.000358	CbGpPWpGaD
Trazodone—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—chronic obstructive pulmonary disease	1.66e-05	0.000357	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	1.63e-05	0.000352	CbGpPWpGaD
Trazodone—ADRA1A—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	1.63e-05	0.000352	CbGpPWpGaD
Trazodone—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—chronic obstructive pulmonary disease	1.63e-05	0.000351	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—KL—chronic obstructive pulmonary disease	1.62e-05	0.000349	CbGpPWpGaD
Trazodone—ADRA2A—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	1.61e-05	0.000347	CbGpPWpGaD
Trazodone—HTR1A—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	1.6e-05	0.000346	CbGpPWpGaD
Trazodone—ADRA2A—Hemostasis—SERPINE1—chronic obstructive pulmonary disease	1.6e-05	0.000345	CbGpPWpGaD
Trazodone—ADRA2A—Hemostasis—ALB—chronic obstructive pulmonary disease	1.6e-05	0.000345	CbGpPWpGaD
Trazodone—HTR2C—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	1.6e-05	0.000344	CbGpPWpGaD
Trazodone—ABCB1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	1.59e-05	0.000344	CbGpPWpGaD
Trazodone—ADRA2A—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	1.59e-05	0.000342	CbGpPWpGaD
Trazodone—HTR2A—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	1.58e-05	0.000341	CbGpPWpGaD
Trazodone—HRH1—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	1.58e-05	0.000341	CbGpPWpGaD
Trazodone—ADRA2A—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.58e-05	0.00034	CbGpPWpGaD
Trazodone—ADRA2A—Metabolism—GCLC—chronic obstructive pulmonary disease	1.56e-05	0.000336	CbGpPWpGaD
Trazodone—ADRA1A—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	1.55e-05	0.000334	CbGpPWpGaD
Trazodone—ADRA2A—Hemostasis—NOS3—chronic obstructive pulmonary disease	1.53e-05	0.00033	CbGpPWpGaD
Trazodone—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	1.53e-05	0.000329	CbGpPWpGaD
Trazodone—HRH1—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	1.52e-05	0.000328	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	1.52e-05	0.000327	CbGpPWpGaD
Trazodone—ADRA2A—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	1.52e-05	0.000327	CbGpPWpGaD
Trazodone—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	1.5e-05	0.000322	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	1.5e-05	0.000322	CbGpPWpGaD
Trazodone—ADRA1A—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	1.49e-05	0.000322	CbGpPWpGaD
Trazodone—CYP3A5—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.45e-05	0.000312	CbGpPWpGaD
Trazodone—ADRA2A—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	1.44e-05	0.00031	CbGpPWpGaD
Trazodone—CYP3A5—Metabolism—GCLC—chronic obstructive pulmonary disease	1.43e-05	0.000308	CbGpPWpGaD
Trazodone—ADRA2A—Metabolism—CTGF—chronic obstructive pulmonary disease	1.43e-05	0.000307	CbGpPWpGaD
Trazodone—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	1.42e-05	0.000307	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	1.41e-05	0.000304	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	1.41e-05	0.000303	CbGpPWpGaD
Trazodone—CYP3A7—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.39e-05	0.000299	CbGpPWpGaD
Trazodone—ADRA2A—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	1.39e-05	0.000299	CbGpPWpGaD
Trazodone—HRH1—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	1.38e-05	0.000298	CbGpPWpGaD
Trazodone—CYP3A7—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.37e-05	0.000295	CbGpPWpGaD
Trazodone—ADRA1A—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	1.36e-05	0.000292	CbGpPWpGaD
Trazodone—HTR2B—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	1.35e-05	0.00029	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	1.34e-05	0.000288	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—KL—chronic obstructive pulmonary disease	1.31e-05	0.000283	CbGpPWpGaD
Trazodone—ADRA2A—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.31e-05	0.000283	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—KL—chronic obstructive pulmonary disease	1.31e-05	0.000282	CbGpPWpGaD
Trazodone—CYP3A5—Metabolism—CTGF—chronic obstructive pulmonary disease	1.31e-05	0.000281	CbGpPWpGaD
Trazodone—CYP3A7—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.28e-05	0.000275	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.27e-05	0.000273	CbGpPWpGaD
Trazodone—ADRA2A—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	1.26e-05	0.000272	CbGpPWpGaD
Trazodone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	1.26e-05	0.000271	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	1.23e-05	0.000265	CbGpPWpGaD
Trazodone—HTR2B—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	1.22e-05	0.000263	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	1.22e-05	0.000263	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	1.22e-05	0.000262	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	1.21e-05	0.000262	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	1.21e-05	0.000261	CbGpPWpGaD
Trazodone—CYP3A7—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.21e-05	0.000261	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	1.21e-05	0.00026	CbGpPWpGaD
Trazodone—CYP3A5—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.2e-05	0.000259	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	1.2e-05	0.000257	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	1.17e-05	0.000252	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.15e-05	0.000247	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—KL—chronic obstructive pulmonary disease	1.13e-05	0.000244	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—KL—chronic obstructive pulmonary disease	1.13e-05	0.000244	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—KL—chronic obstructive pulmonary disease	1.11e-05	0.000239	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	1.11e-05	0.000239	CbGpPWpGaD
Trazodone—ADRA2A—Hemostasis—VEGFA—chronic obstructive pulmonary disease	1.1e-05	0.000237	CbGpPWpGaD
Trazodone—ADRA2A—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.1e-05	0.000236	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.09e-05	0.000235	CbGpPWpGaD
Trazodone—HTR1A—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	1.09e-05	0.000235	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—LEP—chronic obstructive pulmonary disease	1.09e-05	0.000234	CbGpPWpGaD
Trazodone—HTR2C—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	1.09e-05	0.000234	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	1.08e-05	0.000233	CbGpPWpGaD
Trazodone—ADRA2A—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.08e-05	0.000233	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—GCLC—chronic obstructive pulmonary disease	1.08e-05	0.000233	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	1.08e-05	0.000232	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	1.05e-05	0.000226	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	1.05e-05	0.000225	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—KL—chronic obstructive pulmonary disease	1.03e-05	0.000222	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.03e-05	0.000222	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	1.03e-05	0.000221	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—GCLC—chronic obstructive pulmonary disease	1.02e-05	0.000219	CbGpPWpGaD
Trazodone—ADRA2A—Hemostasis—TGFB1—chronic obstructive pulmonary disease	1.01e-05	0.000218	CbGpPWpGaD
Trazodone—ADRA2A—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.01e-05	0.000217	CbGpPWpGaD
Trazodone—CYP3A5—Metabolism—GSTP1—chronic obstructive pulmonary disease	1e-05	0.000216	CbGpPWpGaD
Trazodone—HTR1A—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	9.91e-06	0.000214	CbGpPWpGaD
Trazodone—CYP3A5—Metabolism—HMOX1—chronic obstructive pulmonary disease	9.9e-06	0.000213	CbGpPWpGaD
Trazodone—HTR2C—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	9.86e-06	0.000212	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—CTGF—chronic obstructive pulmonary disease	9.86e-06	0.000212	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	9.85e-06	0.000212	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	9.8e-06	0.000211	CbGpPWpGaD
Trazodone—ABCB1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	9.58e-06	0.000206	CbGpPWpGaD
Trazodone—ADRA2A—Metabolism—CYP1A1—chronic obstructive pulmonary disease	9.54e-06	0.000206	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	9.53e-06	0.000205	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	9.48e-06	0.000204	CbGpPWpGaD
Trazodone—HTR2A—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	9.43e-06	0.000203	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	9.43e-06	0.000203	CbGpPWpGaD
Trazodone—HRH1—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	9.41e-06	0.000203	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	9.36e-06	0.000202	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	9.34e-06	0.000201	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—CTGF—chronic obstructive pulmonary disease	9.29e-06	0.0002	CbGpPWpGaD
Trazodone—ADRA1A—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	9.23e-06	0.000199	CbGpPWpGaD
Trazodone—CYP3A5—Metabolism—GSTM1—chronic obstructive pulmonary disease	9.22e-06	0.000199	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	9.16e-06	0.000197	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	9.08e-06	0.000196	CbGpPWpGaD
Trazodone—HTR2B—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	8.93e-06	0.000192	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—LEP—chronic obstructive pulmonary disease	8.81e-06	0.00019	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—LEP—chronic obstructive pulmonary disease	8.77e-06	0.000189	CbGpPWpGaD
Trazodone—CYP3A5—Metabolism—CYP1A1—chronic obstructive pulmonary disease	8.74e-06	0.000188	CbGpPWpGaD
Trazodone—ADRA2A—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	8.58e-06	0.000185	CbGpPWpGaD
Trazodone—HTR2A—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	8.56e-06	0.000184	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	8.56e-06	0.000184	CbGpPWpGaD
Trazodone—HRH1—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	8.54e-06	0.000184	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	8.53e-06	0.000184	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	8.52e-06	0.000183	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	8.51e-06	0.000183	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	8.49e-06	0.000183	CbGpPWpGaD
Trazodone—ADRA1A—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	8.38e-06	0.000181	CbGpPWpGaD
Trazodone—ADRA2A—Hemostasis—TP53—chronic obstructive pulmonary disease	8.33e-06	0.000179	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	8.33e-06	0.000179	CbGpPWpGaD
Trazodone—CYP3A7—Metabolism—ALB—chronic obstructive pulmonary disease	8.22e-06	0.000177	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	8.17e-06	0.000176	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	8.14e-06	0.000175	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	8.02e-06	0.000173	CbGpPWpGaD
Trazodone—CYP3A7—Metabolism—NOS3—chronic obstructive pulmonary disease	7.87e-06	0.000169	CbGpPWpGaD
Trazodone—ADRA2A—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	7.79e-06	0.000168	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	7.74e-06	0.000167	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—LEP—chronic obstructive pulmonary disease	7.61e-06	0.000164	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—LEP—chronic obstructive pulmonary disease	7.6e-06	0.000164	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—GSTP1—chronic obstructive pulmonary disease	7.57e-06	0.000163	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—HMOX1—chronic obstructive pulmonary disease	7.47e-06	0.000161	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—LEP—chronic obstructive pulmonary disease	7.45e-06	0.000161	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	7.45e-06	0.00016	CbGpPWpGaD
Trazodone—HTR1A—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	7.24e-06	0.000156	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	7.22e-06	0.000156	CbGpPWpGaD
Trazodone—HTR2C—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	7.21e-06	0.000155	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—GSTP1—chronic obstructive pulmonary disease	7.14e-06	0.000154	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—HMOX1—chronic obstructive pulmonary disease	7.04e-06	0.000152	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—GSTM1—chronic obstructive pulmonary disease	6.96e-06	0.00015	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—LEP—chronic obstructive pulmonary disease	6.93e-06	0.000149	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	6.91e-06	0.000149	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	6.88e-06	0.000148	CbGpPWpGaD
Trazodone—HTR2B—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	6.87e-06	0.000148	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	6.73e-06	0.000145	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	6.66e-06	0.000143	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	6.6e-06	0.000142	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	6.6e-06	0.000142	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	6.57e-06	0.000141	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—GSTM1—chronic obstructive pulmonary disease	6.56e-06	0.000141	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	6.53e-06	0.000141	CbGpPWpGaD
Trazodone—ADRA2A—Metabolism—ALB—chronic obstructive pulmonary disease	6.49e-06	0.00014	CbGpPWpGaD
Trazodone—HTR2A—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	6.26e-06	0.000135	CbGpPWpGaD
Trazodone—HRH1—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	6.25e-06	0.000135	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	6.22e-06	0.000134	CbGpPWpGaD
Trazodone—ADRA2A—Metabolism—NOS3—chronic obstructive pulmonary disease	6.2e-06	0.000134	CbGpPWpGaD
Trazodone—ADRA1A—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	6.13e-06	0.000132	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	6.07e-06	0.000131	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	5.97e-06	0.000129	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	5.96e-06	0.000128	CbGpPWpGaD
Trazodone—CYP3A5—Metabolism—ALB—chronic obstructive pulmonary disease	5.94e-06	0.000128	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	5.86e-06	0.000126	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	5.86e-06	0.000126	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	5.85e-06	0.000126	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	5.83e-06	0.000125	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	5.7e-06	0.000123	CbGpPWpGaD
Trazodone—ADRA2A—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	5.69e-06	0.000123	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	5.69e-06	0.000123	CbGpPWpGaD
Trazodone—CYP3A5—Metabolism—NOS3—chronic obstructive pulmonary disease	5.69e-06	0.000122	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	5.6e-06	0.000121	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	5.58e-06	0.00012	CbGpPWpGaD
Trazodone—HTR1A—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	5.57e-06	0.00012	CbGpPWpGaD
Trazodone—HTR2C—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	5.54e-06	0.000119	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	5.43e-06	0.000117	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	5.38e-06	0.000116	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	5.3e-06	0.000114	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	5.28e-06	0.000114	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	5.27e-06	0.000113	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	5.19e-06	0.000112	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	5.06e-06	0.000109	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	5.05e-06	0.000109	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	4.95e-06	0.000107	CbGpPWpGaD
Trazodone—HTR2A—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	4.81e-06	0.000104	CbGpPWpGaD
Trazodone—HRH1—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	4.8e-06	0.000103	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	4.76e-06	0.000102	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	4.73e-06	0.000102	CbGpPWpGaD
Trazodone—ADRA1A—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	4.71e-06	0.000101	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	4.67e-06	0.000101	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	4.6e-06	9.91e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	4.6e-06	9.91e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	4.58e-06	9.86e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	4.57e-06	9.83e-05	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—ALB—chronic obstructive pulmonary disease	4.49e-06	9.66e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	4.48e-06	9.65e-05	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—TP53—chronic obstructive pulmonary disease	4.43e-06	9.54e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	4.38e-06	9.43e-05	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	4.36e-06	9.4e-05	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	4.34e-06	9.35e-05	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—NOS3—chronic obstructive pulmonary disease	4.29e-06	9.24e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	4.29e-06	9.24e-05	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	4.28e-06	9.22e-05	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	4.26e-06	9.17e-05	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—ALB—chronic obstructive pulmonary disease	4.23e-06	9.1e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	4.16e-06	8.97e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	4.11e-06	8.85e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	4.1e-06	8.83e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	4.07e-06	8.76e-05	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—IL6—chronic obstructive pulmonary disease	4.06e-06	8.74e-05	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—NOS3—chronic obstructive pulmonary disease	4.04e-06	8.71e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	4.02e-06	8.67e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	3.77e-06	8.12e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	3.76e-06	8.1e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	3.74e-06	8.05e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	3.7e-06	7.96e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	3.69e-06	7.95e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	3.69e-06	7.95e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	3.62e-06	7.8e-05	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—TP53—chronic obstructive pulmonary disease	3.59e-06	7.74e-05	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—TP53—chronic obstructive pulmonary disease	3.57e-06	7.7e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	3.43e-06	7.39e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	3.36e-06	7.25e-05	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—IL6—chronic obstructive pulmonary disease	3.29e-06	7.08e-05	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—IL6—chronic obstructive pulmonary disease	3.27e-06	7.05e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—TP53—chronic obstructive pulmonary disease	3.1e-06	6.69e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	3.1e-06	6.67e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—TP53—chronic obstructive pulmonary disease	3.04e-06	6.55e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.84e-06	6.12e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.84e-06	6.11e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.82e-06	6.08e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.78e-06	5.99e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	2.76e-06	5.95e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	2.64e-06	5.69e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.59e-06	5.57e-05	CbGpPWpGaD
